Cetrorelix acetas
Synonyma Anglica: N-Acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-L-tyrosyl-N5-(aminocarbonyl)-D-ornithyl-L-leucyl-L-arginyl-L-prolyl-D-alaninamideum diacetatum.;Cetrorelix acetas;Cetrorenlin Acetate
CAS: 130143-01-0
Assay: 98%
Formulae hypotheticae: C70H92N17O14
M. Pondus:1551.16
Consuetudinem: GnRH receptorem promovere est adversarios
Cetrorelix acetate is the acetic acid salt of cetrorelix. A gonadotrophin-releasing hormone (GnRH) antagonist, it is used for treatment of infertility and of hormone-sensitive cancers of the prostate and breast. It has a role as a GnRH antagonist and an antineoplastic agent. It is an oligopeptide and an acetate salt. It contains a cetrorelix.
The use of cetrorelix is contraindicated in severe renal impairment. It is not intended for women aged 65 years or older. Use in women with severe allergic conditions is not recommended. Use with caution in women with active allergies or history of allergies.
| Items |
Specifications |
Proventus |
| Aspectus |
Pulvis albus |
Pulvis albus |
| Identity by HPLC |
The retention is same with the reference substance |
Conforms |
| Specific Optical Rotation |
-20 to -30°(c=1,50%HAc) |
-26.5° |
| Amino Acidum Compositio |
±20% of theoretical |
Conforms |
| Puritas (per HPLC *) |
≥98.0% |
99.11% |
| Related Substance(By HPLC) |
Total Impurities(%)≤2.0%
Largest Single Impurity(%)≤1.0% |
0.89%
0.25% |
| Acetate Content (per HPLC *) |
≤15.0% |
9.7% |
| Aqua Content (by Karl Fischer) |
≤10.0% |
2.2% |
| Bacterial Endotoxins |
≤5EU/mg |
Conforms |
| Peptide Content(N%) |
≥85.0% |
86.5% |
